Cargando…

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United Stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Waheed, Sadia, Bayas, Angel, Hindi, Fawzi, Rizvi, Zufe, Espinosa, Patricio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978140/
https://www.ncbi.nlm.nih.gov/pubmed/33758714
http://dx.doi.org/10.7759/cureus.13426
_version_ 1783667162075889664
author Waheed, Sadia
Bayas, Angel
Hindi, Fawzi
Rizvi, Zufe
Espinosa, Patricio S
author_facet Waheed, Sadia
Bayas, Angel
Hindi, Fawzi
Rizvi, Zufe
Espinosa, Patricio S
author_sort Waheed, Sadia
collection PubMed
description Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.
format Online
Article
Text
id pubmed-7978140
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-79781402021-03-22 Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine Waheed, Sadia Bayas, Angel Hindi, Fawzi Rizvi, Zufe Espinosa, Patricio S Cureus Neurology Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine. Cureus 2021-02-18 /pmc/articles/PMC7978140/ /pubmed/33758714 http://dx.doi.org/10.7759/cureus.13426 Text en Copyright © 2021, Waheed et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Waheed, Sadia
Bayas, Angel
Hindi, Fawzi
Rizvi, Zufe
Espinosa, Patricio S
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
title Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
title_full Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
title_fullStr Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
title_full_unstemmed Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
title_short Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
title_sort neurological complications of covid-19: guillain-barre syndrome following pfizer covid-19 vaccine
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978140/
https://www.ncbi.nlm.nih.gov/pubmed/33758714
http://dx.doi.org/10.7759/cureus.13426
work_keys_str_mv AT waheedsadia neurologicalcomplicationsofcovid19guillainbarresyndromefollowingpfizercovid19vaccine
AT bayasangel neurologicalcomplicationsofcovid19guillainbarresyndromefollowingpfizercovid19vaccine
AT hindifawzi neurologicalcomplicationsofcovid19guillainbarresyndromefollowingpfizercovid19vaccine
AT rizvizufe neurologicalcomplicationsofcovid19guillainbarresyndromefollowingpfizercovid19vaccine
AT espinosapatricios neurologicalcomplicationsofcovid19guillainbarresyndromefollowingpfizercovid19vaccine